You searched for "practice"

1919 results found

Demodex blepharitis: A transatlantic comparison of treatments available in the UK and US

Demodex blepharitis is widely recognised among eyecare professionals as an important cause of chronic lid margin inflammation, dry eye and ocular surface diseases. The characteristic feature for diagnosis is the presence of waxy deposit at the lash bases on slit...

An interview with Rachel Morris: Clinician wellbeing and difficult conversations

In the last wellbeing supplement, I interviewed Robert Self, Vice President of the Association of Anaesthetists, and we discussed the resources that doctors can access when experiencing problems with their wellbeing. One of those that he recommended was the podcast...

Eye Capacity: clinical need should drive ophthalmic service provision

Almost two million people in the UK suffer sight loss, a number forecast to double over coming decades. Major causes of blindness are age-related macular degeneration (AMD), glaucoma, diabetic retinopathy, cataract and uncorrected refractive error. Prevalence of these sight-threatening conditions...

Glaucoma care provision using a multidisciplinary approach: a personal view

This article is going to explain the secret to running an efficient multidisciplinary glaucoma service which will comfortably meet the demands of an ever-growing elderly population, within the confines of budgetary and clinical constraints, wherever the setting. This may be...

Sexually transmitted conjunctivitis – the REALLY sticky eye

Let’s face it, patients with conjunctivitis don’t always produce the most stimulating consultations and most of the time we can manage them in auto-pilot. The prospect of delving into such a patient’s sexual history is not overly appealing, but this...

SeeAbility’s Martyn Howlett wins at Optician Awards 2024

SeeAbility are delighted to announce that Senior Dispensing Optician and Dispensing Team Lead Martyn Howlett has won Dispensing Optician of the Year at the 2024 Optician Awards. The awards have been running for over 25 years and are a mainstay...

Know Your Risk: Glaucoma UK launches interactive online quiz to help prevent sight loss

Glaucoma is one of the leading causes of blindness in the UK – it can affect anyone, at any time, and is often symptomless. Approximately 700,000 people in the UK have glaucoma, but 50% of them don’t know - if...

IVT Aflibercept 2mg in nAMD: XTEND at 3 years

This study investigated the long-term, effectiveness and safety of IVT-AFL 2mg for neovascular age-related macular degeneration (nAMD). XTEND was a multicentre, observational, prospective study, which was conducted across 127 centres across 17 countries with a follow-up period of 36 months....

The Scottish Government Scholarship in Ophthalmology: just a few weeks left to apply!

A number of scholarships are available for eye healthcare professionals working in Scotland who have been accepted for admission to the online MSc in Primary Care Ophthalmology programme in academic year 2021-2022, thanks to funding from the Scottish Government.

What's trending Dec/Jan 2021

A round-up of the eye-related hot topics that have been trending on social media over the last few weeks. #threeblindmice US company Nanoscope Therapeutics has developed a new treatment which is hoped will restore vision in those affected by retinal...

Uncertainties and opportunities in ophthalmology training after the COVID-19 pandemic

Alexander Jones asks what impact the current pandemic will have on ophthalmology trainees. In my work as a Clinical Teaching Fellow, I have to admit that chaos is uncommon. Neither the anxious excitement of rushing to help an unwell patient...

High-stakes scenarios in retinal vein occlusion: A survey of medico-legal implications

Central retinal vein occlusion (CRVO) is the second most common retinal vascular disease after diabetic retinopathy, and its clinical complexity often intersects with medico-legal scrutiny [1]. Missteps in timely diagnosis, inadequate follow-up or poor documentation can lead to patient harm...